Italy· 019184050
MODALINA*30 cpr rivestite 1 mg
A trifluoperazine product containing trifluoperazina, registered in Italy by SIT LABORATORIO FARMAC. Srl, on the national reimbursement list. The same ATC class is registered in 5 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Trifluoperazine is registered in 5 of 19 countries.
Countries holding a registration under ATC N05AB06 (trifluoperazine), each read from that country’s own register.
- This record: Italy
- 3 of them publish a price we can compare per daily dose
Trifluoperazine · ATC N05AB06
5 / 19 countries
- Finlandprice
- Ireland
- Italyprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of trifluoperazine costs, country by country.
Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.
- Italy: $1.02 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Trifluoperazine · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- IT Italy$1.02
The record
At a glance
- Active substance
- Trifluoperazina
- Manufacturer
- SIT LABORATORIO FARMAC. Srl
- Country
- Italy (IT)
- ATC code
- N05AB06
- ATC class
- Trifluoperazine
- Defined daily dose
- 20 mg, O
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic019184050MODALINA*30 cpr rivestite 1 mgEUR 1.6
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
345 interactions on record for trifluoperazine.
Graded by severity as the source publishes them — 49 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Trifluoperazine · interactions on record
345 records
- 49 severe
- 287 moderate
- 9 minor
Most severe, free to view
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Potassium chlorideA12BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Trifluoperazine in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomStelazine 10mg SpansulesMercury Pharma Group Ltd
- United StatesTrifluoperazine HydrochlorideBryant Ranch Prepack
- IrelandStelazine 1mg Film-coated TabletsAmdipharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Cyprus · Stelazine, Trifluoperazine Remedica
- United Kingdom (Northern Ireland) · Stelazine, Trifluoperazine
- Greece · Stelazine
- Ireland · Stelazine
- Malta · Trifluoperazine Remedica
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a88472bc-198e-483b-abf1-f45546c047d1 GET /v1/drugs/a88472bc-198e-483b-abf1-f45546c047d1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 1.6,
"source": "aifa",
"currency": "EUR",
"strength": "TRIFLUOPERAZINA 1MG 30 UNITA' USO ORALE",
"substance": "Trifluoperazina",
"equivalence_group": "T2A",
"transparency_flag": null
}See everything about trifluoperazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.